• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄、体重指数、吸烟及总体健康状况对复方口服避孕药使用者发生静脉血栓栓塞风险的影响。

The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives.

作者信息

Nightingale A L, Lawrenson R A, Simpson E L, Williams T J, MacRae K D, Farmer R D

机构信息

Department of Pharmacoepidemiology and Primary Care, Postgraduate Medical School, University of Surrey, Guildford, UK.

出版信息

Eur J Contracept Reprod Health Care. 2000 Dec;5(4):265-74. doi: 10.1080/13625180008500402.

DOI:10.1080/13625180008500402
PMID:11245554
Abstract

OBJECTIVES

To investigate the factors associated with idiopathic venous thromboembolism in combined oral contraceptive users and to estimate the crude and age-specific incidence rates ofidiopathic venous thromboembolism among this population.

METHODS

The UK MediPlus Database and the General Practice Research Database were searched to identify women with evidence of venous thromboembolism while exposed to combined oral contraceptives. Cohort and nested case-control studies were carried out using the same methodology on both databases. We conducted a meta-analysis using the individual data for the cases and controls from the two case-control studies to identify factors associated with idiopathic venous thromboembolism in women using combined oral contraceptives.

RESULTS

The incidence rate of idiopathic venous thromboembolism among oral contraceptive users was 39.4 per 100,000 exposed woman-years. The age-specific incidence rates were found to rise sharply after the age of 39 years. Factors identified as being significantly associated with idiopathic venous thromboembolism in women using combined oral contraceptives were: body mass index of 25 kg/m2 and over, the association rising dramatically in women with a body mass index of 35 kg/m2 or more; smoking; general ill health; and asthma.

CONCLUSION

We believe that, before prescribing combined oral contraceptives, the venous as well as the arterial factors need to be considered and, in addition, age, obesity and smoking are all relevant when assessing an individual patient's risk.

摘要

目的

调查复方口服避孕药使用者特发性静脉血栓栓塞的相关因素,并估算该人群特发性静脉血栓栓塞的粗发病率和年龄特异性发病率。

方法

检索英国MediPlus数据库和全科医疗研究数据库,以确定在使用复方口服避孕药期间有静脉血栓栓塞证据的女性。对两个数据库采用相同方法进行队列研究和巢式病例对照研究。我们对两项病例对照研究中病例和对照的个体数据进行荟萃分析,以确定复方口服避孕药使用者特发性静脉血栓栓塞的相关因素。

结果

口服避孕药使用者中特发性静脉血栓栓塞的发病率为每100,000暴露女性年39.4例。发现年龄特异性发病率在39岁以后急剧上升。确定与复方口服避孕药使用者特发性静脉血栓栓塞显著相关的因素为:体重指数25kg/m2及以上,体重指数35kg/m2或更高的女性中该关联显著增加;吸烟;总体健康状况不佳;以及哮喘。

结论

我们认为,在开具复方口服避孕药之前,需要考虑静脉和动脉因素,此外,在评估个体患者风险时,年龄、肥胖和吸烟均与之相关。

相似文献

1
The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives.年龄、体重指数、吸烟及总体健康状况对复方口服避孕药使用者发生静脉血栓栓塞风险的影响。
Eur J Contracept Reprod Health Care. 2000 Dec;5(4):265-74. doi: 10.1080/13625180008500402.
2
Population-based study of risk of venous thromboembolism associated with various oral contraceptives.基于人群的与各种口服避孕药相关的静脉血栓栓塞风险研究。
Lancet. 1997 Jan 11;349(9045):83-8. doi: 10.1016/s0140-6736(96)07496-x.
3
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.使用含不同孕激素成分口服避孕药的女性发生特发性心血管死亡和非致命性静脉血栓栓塞的风险。
Lancet. 1995 Dec 16;346(8990):1589-93. doi: 10.1016/s0140-6736(95)91928-7.
4
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.静脉血栓栓塞性疾病与复方口服避孕药:对MediPlus数据库的重新分析
Hum Reprod. 1999 Jun;14(6):1500-5. doi: 10.1093/humrep/14.6.1500.
5
Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.口服避孕药与静脉血栓栓塞性疾病:英国和德国数据库研究的结果
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 2):S78-86. doi: 10.1053/ob.1998.v179.a92634.
6
A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.不同复方口服避孕药相关的静脉血栓栓塞性疾病风险比较。
Br J Clin Pharmacol. 2000 Jun;49(6):580-90. doi: 10.1046/j.1365-2125.2000.00198.x.
7
Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.1995年避孕药恐慌对服用复方口服避孕药女性静脉血栓栓塞发生率的影响:基于全科医疗研究数据库的分析
BMJ. 2000;321(7259):477-9. doi: 10.1136/bmj.321.7259.477.
8
Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database.口服避孕药与静脉血栓栓塞性疾病。英国全科医疗研究数据库及英国Mediplus数据库分析
Hum Reprod Update. 1999 Nov-Dec;5(6):688-706. doi: 10.1093/humupd/5.6.688.
9
Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.含屈螺酮或左炔诺孕酮的口服避孕药使用者的静脉血栓栓塞风险:基于英国普通实践研究数据库的巢式病例对照研究。
BMJ. 2011 Apr 21;342:d2139. doi: 10.1136/bmj.d2139.
10
Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.复方口服避孕药的使用与静脉血栓栓塞风险:利用QResearch和CPRD数据库进行的巢式病例对照研究
BMJ. 2015 May 26;350:h2135. doi: 10.1136/bmj.h2135.

引用本文的文献

1
Using updated clinical recommendations to support contraceptive decision-making: U.S. medical eligibility criteria for contraceptive use, 2024.利用最新临床建议支持避孕决策:2024年美国避孕使用医学资格标准
Contraception. 2025 Jul 14:111015. doi: 10.1016/j.contraception.2025.111015.
2
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.美国避孕方法医学适用标准,2024 年版。
MMWR Recomm Rep. 2024 Aug 8;73(4):1-126. doi: 10.15585/mmwr.rr7304a1.
3
U.S. Selected Practice Recommendations for Contraceptive Use, 2024.美国 2024 年避孕方法选择实践推荐
MMWR Recomm Rep. 2024 Aug 8;73(3):1-77. doi: 10.15585/mmwr.rr7303a1.
4
Preconception indicators and associations with health outcomes reported in UK routine primary care data: a systematic review.英国常规初级保健数据中报告的孕前指标及其与健康结局的关联:一项系统综述。
Br J Gen Pract. 2025 Jan 30;75(751):e129-e136. doi: 10.3399/BJGP.2024.0082. Print 2025 Feb.
5
Sex Hormone Treatment for Female Children and Young Adults with Disorders Affecting Hypothalamic, Pituitary, and Ovarian Function.针对患有影响下丘脑、垂体和卵巢功能疾病的女童及年轻女性的性激素治疗。
Horm Res Paediatr. 2025;98(5):585-596. doi: 10.1159/000539697. Epub 2024 Jun 7.
6
Obesity and contraceptive use: impact on cardiovascular risk.肥胖与避孕措施的使用:对心血管风险的影响。
ESC Heart Fail. 2022 Dec;9(6):3761-3767. doi: 10.1002/ehf2.14104. Epub 2022 Sep 14.
7
Practical Approach to Hyperandrogenism in Women.女性高雄激素血症的实用诊疗方法
Med Clin North Am. 2021 Nov;105(6):1099-1116. doi: 10.1016/j.mcna.2021.06.008. Epub 2021 Sep 8.
8
Case 5/2017 - A 28-Year-Old Woman with Cor Pulmonale Due to Pulmonary Hypertension Secondary to Chronic Pulmonary Thromboembolism.病例5/2017 - 一名28岁因慢性肺血栓栓塞继发肺动脉高压导致肺心病的女性
Arq Bras Cardiol. 2017 Oct;109(4):370-375. doi: 10.5935/abc.20170148.
9
Evaluation of Cardiometabolic Parameters among Obese Women Using Oral Contraceptives.使用口服避孕药的肥胖女性心血管代谢参数评估
Front Endocrinol (Lausanne). 2017 Sep 29;8:256. doi: 10.3389/fendo.2017.00256. eCollection 2017.
10
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.利用日本药品不良事件报告数据库对雌激素-孕激素联合制剂进行的血栓栓塞不良事件研究
PLoS One. 2017 Jul 21;12(7):e0182045. doi: 10.1371/journal.pone.0182045. eCollection 2017.